The role of sentinel lymph node biopsy in surgical oncology;Az orszemnyirokcsomó-biopszia jelentosége a daganatsebészetben

Lege Artis Medicinae

Volumn 12, Issue 1, 2002, Pages 18-26

  Péley, Gábor ^a   Köves, István ^a   Sinkovics, István ^a   Farkas, Emil ^a   Dubecz, Sándor ^a   Kovács, Tibor ^a   Keresztes, Sándor ^a   Vámosi Nagy, István ^a  

^a Általános És Mellkassebészeti Osztály   (Hungary)

Author keywords

Malignant tumor; Regional lymphadenectomy; Regional staging; Sentinel lymph node biopsy; Surgical treatment

Indexed keywords

CANCER STAGING; CANCER SURGERY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; REVIEW; SENTINEL LYMPH NODE BIOPSY;

EID: 0036173803     PISSN: 08664811     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Biologic and clinical significance of lymphadenectomy
2. Observations on a "sentinel node" in cancer of the parotid
3. An approach for the treatment of penile carcinoma
4. Technical details of intraoperative lymphatic mapping for early stage melanoma
5. Lymphatic drainage of skin to a sentinel lymph node in a feline model
6. Gamma-probe-guided localization of lymph nodes
7. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma
8. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. A preliminary study
9. Immunohistochemistry and reverse transcriptase polymerase-chain reaction on sentinel lymph nodes can improve the accuracy of nodal staging in breast cancer patients
10. Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumors
11. Biological behaviour and clinical implications of micrometastases
12. Classification of isolated tumor cells and micrometastasis
13. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma
14. Intraoperative pathologic examination of the sentinel lymph node
15. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer
16. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
17. The sentinel node in breast cancer. A multicentric validation study
18. Az intraoperatív gamma-próba által vezérelt orszemnyirokcsomóbiopszia jelentosége a melanoma malignum és az emlorák kezelésében
19. A kettos jelöléses orszemnyirokcsomó-biopszia sebészi alkalmazhatósága és pontossága emlorákban
20. Therapeutic node dissection in malignant melanoma
21. Lymphoscintigraphy in high-risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node
22. Lymphatic drainage from the skin of the back to retroperitoneal and paravertabral lymph nodes in melanoma patients
23. Prediction of potential metastatic sites in cutaneus head and neck melanoma using lymphoscintigraphy
24. Sentinel nodes outside lymph node basins in patients with melanoma
25. Efficacy of immediate node dissection of stage II melanoma
26. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial
27. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
28. Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins
29. Melanoma malignum sentinel nyirokcsomójának eltávolításában szerzett kezdeti tapasztalataink
30. Detection of microscopic melanoma metastases in sentinel lymph nodes
31. Molecular staging of malignant melanoma. Correlation with clinical outcome
32. A new American Joint Committee on Cancer staging system for cutaneus melanoma
33. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
34. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma
35. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma
36. Axillary lymphadenectomy: A diagnostic and therapeutic procedure
37. Axillary lymph nodes and breast cancer. A review
38. Pathologic findings from the national surgical adjuvant breast project protocol B-06: 10-Year pathologic and clinical prognostic discriminants
39. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer?
40. Staging of the axilla in breast cancer. Accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-d-glucose
41. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators
42. Physical and psychological morbidity after axillary lymph node dissection for breast cancer
43. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
44. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma-probe detection
45. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
46. Value of axillary sentinel nodal status in breast cancer
47. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
48. Improved axillary staging of breast cancer with sentinel lymphadenectomy
49. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
50. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up
51. The value of lymph-node dissection in patients with differentiated thyroid cancer
52. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer
53. Differentiated thyroid cancer: Reexamination of risk groups and outcome of treatment
54. Impact of neck dissection on survival in well-differentiated thyroid cancer: A multifactorial analysis of 218 cases
55. Sentinel lymphadenectomy in thyroid malignant neoplasms
56. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms
57. Sentinel lymph node dissection for thyroid malignancy
58. Sentinel lymph node biopsy in the management of thyroid disease
59. Epidermoid carcinoma of the anal canal. A series of 276 cases
60. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter conserving treatment
61. Epidermoid carcinomas of the anorectum
62. The sentinel node in anal carcinoma
63. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal. Experience in a series of 270 patients treated in Lyon and review of the literature
64. Potential and futility of sentinel node detection for gastric cancer
65. Application of sentinel node biopsy to gastric cancer surgery
66. Intraoperative lymphatic mapping and the sentinel node concept in colon carcinoma
67. Intraoperative lymphatic mapping and the sentinel node concept in colon carcinoma
68. Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms
69. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging
70. The role of sentinel lymph node mapping in staging of colon and rectal cancer
71. Ex vivo sentinel node mapping in carcinoma of the colon and rectum
72. Diagnostic use of the sentinel node in colon cancer
73. Molecular staging of early colon cancer on the basis of sentinel node analysis: Multicenter phase II trial
74. Endoscopic gastrointestinal lymphoscintigraphy